Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stroke × Norepinephrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiodermatitis 3 Head and Neck Neoplasms 3 Hypotension 2 Stroke 1 Shock, Septic 1 Optimal Tissue Perfusion 1 Neoplasms 1 Mouth Neoplasms 1 Leiomyoma 1 Alopecia 1

Interventions

Transcranial Direct Current Stimulation 2 Nutrition Assessment 2 tocilizumab 1 rimabotulinumtoxinB 1 X-Rays 1 Vitamin B 6 1 Vitamin B 12 1 Thrombectomy 1 Standard of Care 1 Rosuvastatin Calcium 1 Practice Guidelines as Topic 1 Phenylephrine 1 Norepinephrine 1 Neuropsychological Tests 1 Music Therapy 1 Massage 1 Lysine Acetyltransferase 5 1 Infliximab 1 Immunoglobulin G 1 Folic Acid 1 Exergaming 1 Enoxaparin 1 Disulfides 1 Dialectical Behavior Therapy 1 Cholecalciferol 1 Cerebral Angiography 1 Botulinum Toxins, Type A 1 Aspirin 1 Animal Assisted Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06711432 2024-12-02

PRECISION

Zhejiang Cancer Hospital

Phase NA Recruiting

Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡